Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.

FESS chronic rhinosinusitis cystic fibrosis dysphonia evidence-based medicine sinus voice and allergy

Journal

International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261

Informations de publication

Date de publication:
09 2022
Historique:
revised: 05 01 2022
received: 06 10 2021
accepted: 07 01 2022
pubmed: 29 1 2022
medline: 31 8 2022
entrez: 28 1 2022
Statut: ppublish

Résumé

Cystic fibrosis (CF) is a multisystem disease that often requires otolaryngology care. Individuals with CF commonly have chronic rhinosinusitis but also present with hearing loss and dysphonia. Given these manifestations of CF, otolaryngologists are frequently involved in the care of patients with CF; however, there is limited consensus on optimal management of sinonasal, otologic, and laryngologic symptoms. The Cystic Fibrosis Foundation convened a multidisciplinary team of otolaryngologists, pulmonologists, audiologists, pharmacists, a social worker, a nurse coordinator, a respiratory therapist, two adults with CF, and a caregiver of a child with CF to develop consensus recommendations. Workgroups developed draft recommendation statements based on a systematic literature review, and a ≥80% consensus was required for acceptance of each recommendation statement. The committee voted on 25 statements. Eleven statements were adopted recommending a treatment or intervention, while five statements were formulated recommending against a specific treatment or intervention. The committee recommended eight statements as an option for select patients in certain circumstances, and one statement did not reach consensus. These multidisciplinary consensus recommendations will help providers navigate decisions related to otolaryngology consultation, medical and surgical management of CF-CRS, hearing, and voice in individuals with CF. A collaborative and multidisciplinary approach is advocated to best care for our patients with CF. Future clinical research is needed utilizing standardized, validated outcomes with comprehensive reporting of patient outcome, effects of modulator therapies, and genetic characteristics to help continue to advance care, decrease morbidity, and improve the quality of life for individuals with CF.

Sections du résumé

BACKGROUND
Cystic fibrosis (CF) is a multisystem disease that often requires otolaryngology care. Individuals with CF commonly have chronic rhinosinusitis but also present with hearing loss and dysphonia. Given these manifestations of CF, otolaryngologists are frequently involved in the care of patients with CF; however, there is limited consensus on optimal management of sinonasal, otologic, and laryngologic symptoms.
METHODS
The Cystic Fibrosis Foundation convened a multidisciplinary team of otolaryngologists, pulmonologists, audiologists, pharmacists, a social worker, a nurse coordinator, a respiratory therapist, two adults with CF, and a caregiver of a child with CF to develop consensus recommendations. Workgroups developed draft recommendation statements based on a systematic literature review, and a ≥80% consensus was required for acceptance of each recommendation statement.
RESULTS
The committee voted on 25 statements. Eleven statements were adopted recommending a treatment or intervention, while five statements were formulated recommending against a specific treatment or intervention. The committee recommended eight statements as an option for select patients in certain circumstances, and one statement did not reach consensus.
CONCLUSION
These multidisciplinary consensus recommendations will help providers navigate decisions related to otolaryngology consultation, medical and surgical management of CF-CRS, hearing, and voice in individuals with CF. A collaborative and multidisciplinary approach is advocated to best care for our patients with CF. Future clinical research is needed utilizing standardized, validated outcomes with comprehensive reporting of patient outcome, effects of modulator therapies, and genetic characteristics to help continue to advance care, decrease morbidity, and improve the quality of life for individuals with CF.

Identifiants

pubmed: 35089650
doi: 10.1002/alr.22974
pmc: PMC9545592
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1089-1103

Informations de copyright

© 2022 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.

Références

Nature. 1991 Oct 3;353(6343):434-7
pubmed: 1716739
Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8
pubmed: 19729669
Laryngoscope. 2018 Aug;128(8):1752-1758
pubmed: 29193105
Am J Med. 1992 Jan;92(1):61-8
pubmed: 1731511
Otolaryngol Head Neck Surg. 2014 Oct;151(4):542-53
pubmed: 25274375
Laryngoscope. 2007 Mar;117(3):475-9
pubmed: 17279057
Eur J Pediatr. 2003 Jul;162(7-8):488-489
pubmed: 12719971
J Otolaryngol. 2007 Oct;36(5):257-63
pubmed: 17963663
Front Cell Neurosci. 2017 Oct 09;11:308
pubmed: 29062271
Ann Am Thorac Soc. 2022 Jan;19(1):12-19
pubmed: 34436985
Otolaryngol Head Neck Surg. 2018 Nov;159(5):887-894
pubmed: 29914288
Am J Rhinol Allergy. 2014 Mar-Apr;28(2):156-63
pubmed: 24598043
Can Fam Physician. 2013 Dec;59(12):1275-81, e528-34
pubmed: 24336538
Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739
pubmed: 33236525
Int J Pediatr Otorhinolaryngol. 1980 Sep;2(3):251-3
pubmed: 6821312
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):293-302
pubmed: 24604103
Arch Otolaryngol Head Neck Surg. 2005 Dec;131(12):1097-101
pubmed: 16365224
Pharmacotherapy. 1999 Feb;19(2):245-8
pubmed: 10030778
Am J Rhinol Allergy. 2012 Jan-Feb;26(1):70-5
pubmed: 22391086
Otolaryngol Head Neck Surg. 2007 Jul;137(1):10-20
pubmed: 17599558
Rhinology. 2014 Dec;52(4):327-33
pubmed: 25479210
Int J Pediatr Otorhinolaryngol. 1994 Jan;28(2-3):141-7
pubmed: 8157412
Rhinology. 2020 Feb 20;58(Suppl S29):1-464
pubmed: 32077450
J Cyst Fibros. 2021 Mar;20(2):284-287
pubmed: 32811788
Am J Rhinol Allergy. 2013 Sep-Oct;27(5):387-95
pubmed: 24119602
Am J Respir Crit Care Med. 2013 Apr 1;187(7):680-9
pubmed: 23540878
Curr Otorhinolaryngol Rep. 2017 Mar;5(1):24-34
pubmed: 28989817
PLoS One. 2014 May 05;9(5):e96769
pubmed: 24796691
Otolaryngol Head Neck Surg. 2012 Sep;147(3):557-62
pubmed: 22517014
Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418802676
pubmed: 30350744
J Cyst Fibros. 2016 Nov;15(6):724-735
pubmed: 27599607
Int Forum Allergy Rhinol. 2017 May;7(5):450-458
pubmed: 28218486
Rhinology. 2016 Sep;54(3):206-13
pubmed: 27116399
Respir Care. 2009 Apr;54(4):522-37
pubmed: 19327189
Laryngoscope. 2018 Jan;128(1):228-236
pubmed: 28771738
Int Forum Allergy Rhinol. 2019 May;9(S1):S4-S8
pubmed: 31087631
Thorax. 2016 Jan;71 Suppl 1:i1-22
pubmed: 26666259
Arch Otolaryngol Head Neck Surg. 2011 Jun;137(6):542-7
pubmed: 21690506
Int J Pediatr Otorhinolaryngol. 2003 Sep;67(9):939-41
pubmed: 12907047
Am J Rhinol Allergy. 2020 Jul;34(4):573-580
pubmed: 32168995
Curr Opin Pulm Med. 2014 Nov;20(6):623-31
pubmed: 25250804
Br J Clin Pharmacol. 1989 Dec;28(6):695-702
pubmed: 2611090
J Clin Invest. 1992 Jan;89(1):339-49
pubmed: 1370301
Cochrane Database Syst Rev. 2015 Jun 22;(6):CD008253
pubmed: 26098667
Int Forum Allergy Rhinol. 2019 Mar;9(3):292-297
pubmed: 30472785
Am J Respir Crit Care Med. 2007 Nov 15;176(10):957-69
pubmed: 17761616
Am J Rhinol. 2006 May-Jun;20(3):317-9
pubmed: 16871936
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
J Antimicrob Chemother. 2016 Mar;71(3):711-7
pubmed: 26626719
Am J Rhinol Allergy. 2019 Jul;33(4):413-419
pubmed: 30931587
Acta Otolaryngol. 1996 May;116(3):472-6
pubmed: 8790750
Otolaryngol Head Neck Surg. 2006 Aug;135(2):248-52
pubmed: 16890077
Otolaryngol Head Neck Surg. 2016 Jul;155(1):160-5
pubmed: 26932969
Pediatrics. 2014 Feb;133(2):350-6
pubmed: 24470639
J Cyst Fibros. 2003 Jun;2(2):72-5
pubmed: 15463853
Eur Arch Otorhinolaryngol. 2019 May;276(5):1341-1347
pubmed: 30689038
PLoS One. 2015 Mar 11;10(3):e0119616
pubmed: 25760329
Otolaryngol Head Neck Surg. 2015 Jul;153(1):88-93
pubmed: 25917663
Cochrane Database Syst Rev. 2019 Jan 18;1:CD011825
pubmed: 30656650
Int Forum Allergy Rhinol. 2016 May;6(5):514-7
pubmed: 26833550
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9262-6
pubmed: 1718002
Pediatr Ann. 2019 Dec 1;48(12):e485-e488
pubmed: 31830288
Otolaryngol Head Neck Surg. 2018 Feb;158(2):381-385
pubmed: 29182491
Int Forum Allergy Rhinol. 2019 Jul;9(7):759-765
pubmed: 31162888
Am J Respir Crit Care Med. 2017 Mar 15;195(6):814-823
pubmed: 27748623
Ann Am Thorac Soc. 2014 Jan;11(1):30-5
pubmed: 24460437
Laryngoscope. 1999 Oct;109(10):1696-702
pubmed: 10522945
J Antimicrob Chemother. 2014 Nov;69(11):3112-5
pubmed: 25016384
Eur Rev Med Pharmacol Sci. 2014;18(14):1985-9
pubmed: 25027336
PLoS One. 2019 Nov 6;14(11):e0224561
pubmed: 31693679
Curr Allergy Asthma Rep. 2019 Feb 22;19(2):14
pubmed: 30796536
Clin Otolaryngol Allied Sci. 2002 Jun;27(3):179-82
pubmed: 12071993
Lancet. 1990 May 5;335(8697):1077-8
pubmed: 1970379
Am J Rhinol Allergy. 2018 Sep;32(5):432-439
pubmed: 30112923
Am J Rhinol Allergy. 2014 Jan-Feb;28(1):e80-2
pubmed: 24717893
Laryngoscope. 1996 Aug;106(8):1005-9
pubmed: 8699890
Br J Clin Pharmacol. 2019 Sep;85(9):1984-1993
pubmed: 31112621
Am J Rhinol. 2008 Nov-Dec;22(6):658-62
pubmed: 19178809
Int Forum Allergy Rhinol. 2022 Sep;12(9):1089-1103
pubmed: 35089650
Pediatr Pulmonol. 2000 Dec;30(6):481-9
pubmed: 11109061
Otolaryngol Head Neck Surg. 2014 Mar;150(3):378-84
pubmed: 24384545
Am J Audiol. 2021 Oct 11;30(3S):800-809
pubmed: 34549989
Clin Infect Dis. 2003 Oct 1;37 Suppl 3:S225-64
pubmed: 12975753
JAMA Otolaryngol Head Neck Surg. 2014 Oct;140(10):934-9
pubmed: 25144751
Rhinology. 2013 Sep;51(3):222-30
pubmed: 23943728
Laryngoscope. 2018 Dec;128(12):2893-2897
pubmed: 30195275
J Cyst Fibros. 2018 Mar;17(2):153-178
pubmed: 29506920
Otolaryngol Head Neck Surg. 2003 Jan;128(1):17-26
pubmed: 12574754
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006394
pubmed: 17636843
Int J Pediatr Otorhinolaryngol. 2001 Nov 1;61(2):113-9
pubmed: 11589977
Clin Otolaryngol. 2009 Oct;34(5):447-54
pubmed: 19793277
Infect Control Hosp Epidemiol. 2014 Aug;35 Suppl 1:S1-S67
pubmed: 25025126
Laryngoscope. 2017 Sep;127(9):1976-1982
pubmed: 28397270
Int J Audiol. 2011 Feb;50(2):112-22
pubmed: 21265638
Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-S39
pubmed: 25832968
J Cyst Fibros. 2016 Nov;15(6):816-824
pubmed: 27049043
BMJ. 2001 Sep 22;323(7314):658-61
pubmed: 11566828
J Cyst Fibros. 2017 May;16(3):401-409
pubmed: 28238634
Pediatr Pulmonol. 2017 Sep;52(9):1157-1162
pubmed: 28737283
Mil Med. 1998 Nov;163(11):792-3
pubmed: 9819544
Otolaryngol Head Neck Surg. 2018 Feb;158(2):203-214
pubmed: 29389303
Int Forum Allergy Rhinol. 2015 Dec;5(12):1111-7
pubmed: 26228968
Int Forum Allergy Rhinol. 2013 Oct;3(10):814-22
pubmed: 23839953
Int Forum Allergy Rhinol. 2021 Feb;11(2):201-203
pubmed: 33070454
Drug Des Devel Ther. 2014 Feb 10;8:209-17
pubmed: 24596456
Int Forum Allergy Rhinol. 2018 Jun;8(6):729-736
pubmed: 29323796
Int J Audiol. 2018 Dec;57(12):917-924
pubmed: 30382794
Ann Allergy Asthma Immunol. 2004 Feb;92(2):228-33
pubmed: 14989391
Ann Otol Rhinol Laryngol. 2018 Oct;127(10):687-693
pubmed: 30032669
Int J Pediatr Otorhinolaryngol. 2017 Nov;102:133-137
pubmed: 29106860
J Cyst Fibros. 2014 Jul;13(4):455-60
pubmed: 24656944
Int J Pediatr Otorhinolaryngol. 2020 Sep;136:110084
pubmed: 32622251
Otolaryngol Head Neck Surg. 2009 Jul;141(1):86-90
pubmed: 19559964
J Antimicrob Chemother. 2020 Aug 1;75(8):2291-2298
pubmed: 32464660
J Cyst Fibros. 2016 Nov;15(6):e57-e66
pubmed: 27267518
Rhinology. 2000 Jun;38(2):63-5
pubmed: 10953842
J Gerontol A Biol Sci Med Sci. 2017 May 01;72(5):703-709
pubmed: 27071780
Ann Otol Rhinol Laryngol. 2009 Mar;118(3):161-5
pubmed: 19374145
Int Forum Allergy Rhinol. 2021 Jan;11(1):75-78
pubmed: 32985756
Laryngoscope. 2014 Jun;124(6):1308-13
pubmed: 24338982
J Cyst Fibros. 2015 Mar;14(2):248-54
pubmed: 25127922
Int J Pediatr Otorhinolaryngol. 2011 Oct;75(10):1318-21
pubmed: 21851991
Otolaryngol Head Neck Surg. 1987 Oct;97(4):356-60
pubmed: 3120101
Otolaryngol Head Neck Surg. 2009 Sep;141(3):358-63
pubmed: 19716014
J Cyst Fibros. 2021 May;20(3):460-463
pubmed: 32694034
Int J Otolaryngol. 2011;2011:937861
pubmed: 22121370
JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):743-9
pubmed: 27228505
J Am Acad Audiol. 2016 Jan;27(1):6-12
pubmed: 26809322

Auteurs

Adam J Kimple (AJ)

Department of Otolaryngology/Head & Neck Surgery, The University of North Carolina, Chapel Hill, North Carolina, USA.

Brent A Senior (BA)

Department of Otolaryngology/Head & Neck Surgery, The University of North Carolina, Chapel Hill, North Carolina, USA.

Edward T Naureckas (ET)

Department of Pulmonary Medicine, Critical Care Medicine, University of Chicago Medicine, Chicago, Illinois, USA.

David A Gudis (DA)

Department of Otolaryngology - Head and Neck Surgery, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.

Ted Meyer (T)

Department of Otolaryngology/Head & Neck Surgery, The University of North Carolina, Chapel Hill, North Carolina, USA.
Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, South Carolina, USA.

Sarah E Hempstead (SE)

Cystic Fibrosis Foundation, Bethesda, Maryland, USA.

Helaine E Resnick (HE)

Resnick, Chodorow & Associates, USA.

Dana Albon (D)

Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA.

Wayne Barfield (W)

Pediatric and Adult CF Center, Medical University of South Carolina, South Carolina, USA.

Margo McKenna Benoit (MM)

Department of Otolaryngology-Head and Neck Surgery, University of Rochester Medical Center, Rochester, New York, USA.

Daniel M Beswick (DM)

Department of Head and Neck Surgery, University of California, Los Angeles, California, USA.

Eliza Callard (E)

Community Advisor to the Cystic Fibrosis Foundation, Bethesda, Maryland, USA.

Shelagh Cofer (S)

Mayo Clinic-Otolaryngology (ENT)/Head and Neck Surgery, Rochester, Minnesota, USA.

Veronica Downer (V)

Michigan Medicine, University of Michigan, Michigan, USA.

E Claire Elson (EC)

Department of Pharmacy, Children's Mercy Kansas City, Kansas City, Missouri, USA.

Angela Garinis (A)

Oregon Hearing Research Center, Oregon Health & Science University, Portland, Oregon, USA.

Ashleigh Halderman (A)

Department of Otolaryngology/Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Lisa Hamburger (L)

Community Advisor to the Cystic Fibrosis Foundation, Bethesda, Maryland, USA.

Meagan Helmick (M)

Community Advisor to the Cystic Fibrosis Foundation, Bethesda, Maryland, USA.

Michael McCown (M)

Department of Pediatrics, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.

Cameron J McKinzie (CJ)

Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA.

Hanna Phan (H)

College of Pharmacy, Department of Clinical Pharmacy, The University of Michigan, C.S. Mott Children's Hospital, Michigan Medicine, Michigan, USA.

Kenneth Rodriguez (K)

Department of Otolaryngology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.

Ronald C Rubenstein (RC)

Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.

Ashley Severin (A)

Department of Social Work, Children's Mercy Kansas City, Kansas City, Missouri, USA.

Gopi Shah (G)

Department of Otolaryngology/Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Ambika Shenoy (A)

Department of Pediatrics, Division of Pediatric Pulmonology, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA.

Brittney Sprouse (B)

Department of Pediatrics, Division of Pediatric Pulmonology, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware, USA.
University of Chicago Medicine, Chicago, Illinois, USA.

Frank Virgin (F)

Department of Otolaryngology - Head and Neck Surgery, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, USA.

Bradford A Woodworth (BA)

Department of Otolaryngology - Head and Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Stella E Lee (SE)

Brigham and Women's Hospital, Division of Otolaryngology-Head & Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH